Citation Impact
Citing Papers
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
2003 StandoutScience
Cancer statistics, 2022
2022 Standout
Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family‐cancer database
2002
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
2003 Standout
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
2018 StandoutScienceNobel
HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica
2001
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
2014 Standout
Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis
2004
Cancer statistics, 2020
2020 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Chlamydia trachomatis and invasive cervical cancer: A pooled analysis of the IARC multicentric case‐control study
2004
The cervical cancer epidemic that screening has prevented in the UK
2004
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Applicability of animal tumor data to cancer therapy in humans
1988
Mammographic Density and the Risk and Detection of Breast Cancer
2007 Standout
Human papillomavirus and cervical cancer
2013
The epidemiology of human papillomavirus infections
2005
Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies
2005
Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA‐positive women with equivocal or mildly abnormal cytology
2005
Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia
2003
Global Cancer Statistics, 2002
2005 Standout
Tobacco and Cancer: Recent Epidemiological Evidence
2004
Epidemiology of HPV infection among Mexican women with normal cervical cytology
2001
Human Papillomaviruses and Cervical Cancer in Bangkok. III. The Role of Husbands and Commercial Sex Workers
2001
Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality
2003
Cervical cancer and use of hormonal contraceptives: a systematic review
2003
Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study
1999
Cancer epidemiology in the last century and the next decade
2001 Nature
Selected major risk factors and global and regional burden of disease
2002 Standout
Head and neck cancer
2008 Standout
Pathology and epidemiology of HPV infection in females
2010
Prevalence and genotyping of HPV in cervical cancer among Australian women
1999
Evidence forChlamydia trachomatisas a Human Papillomavirus Cofactor in the Etiology of Invasive Cervical Cancer in Brazil and the Philippines
2002
Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study
2005
Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors
2013
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
1999 Standout
Heritability of Mammographic Density, a Risk Factor for Breast Cancer
2002
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
Radiosensitization by a new potent nucleoside analog: 1-(1′,3′,4′-trihydroxy-2′-butoxy)methyl-2-nitroimidazole(RP-343)
1993 StandoutNobel
HPV types and cofactors causing cervical cancer in Peru
2001
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Colorectal cancer
2019 Standout
Epidemiology of breast cancer
2001
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
2007
The causal relation between human papillomavirus and cervical cancer
2002 Standout
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
2010 Standout
Chapter 2: Natural History of Anogenital Human Papillomavirus Infection and Neoplasia
2003
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
2012
Human papillomavirus and cervical cancer
2007 Standout
Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
2000
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
2007 Standout
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Sexually transmitted agents and cervical neoplasia in colombia and Spain
1994
Risk factors of invasive cervical cancer in Mali
2002
Mammographic breast density as an intermediate phenotype for breast cancer
2005
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
The natural history of cervical HPV infection: unresolved issues
2006
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
2011 Standout
On the Use of Familial Aggregation in Population-Based Case Probands for Calculating Penetrance
2002
Targeting gene expression to hypoxic tumor cells
1997 StandoutNobel
Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines
1996
Screening for Genital Human Papillomavirus
1999
Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention
2006
N7: A novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age
2001
Neuroblastoma
2007 Standout
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
2012
Cervical cancer
2003
Cervical carcinoma and reproductive factors: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies
2006
Actual Causes of Death in the United States, 2000
2004 Standout
Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States)
2001
Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis
2005
Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus‐like particles in colombian women with invasive cervical cancer
2001
Current methods of testing for human papillomavirus
2001
Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: A pooled analysis of 17 population‐based studies
2012
Male Circumcision for the Prevention of HSV-2 and HPV Infections and Syphilis
2009 Standout
Co-factors related to the causal relationship between human papillomavirus and invasive cervical cancer in Honduras
2000
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Cervical cancer
2019 Standout
Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners
2002
Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening
2005 Standout
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis
2011
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 Standout
High-risk HPV type-specific clearance rates in cervical screening
2007
Human Papillomaviruses and Cervical Cancer in Bangkok. I. Risk Factors for Invasive Cervical Carcinomas with Human Papillomavirus Types 16 and 18 DNA
2001
HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial
2006
Human Papillomaviruses and Cervical Cancer in Bangkok. II. Risk Factors for in Situ and Invasive Squamous Cell Cervical Carcinomas
2001
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 Standout
Analysis of the Effect of DNA Purification on Detection of Human Papillomavirus in Oral Rinse Samples by PCR
2005
Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening
2005
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
2000
Growth and radiosensitivity of malignant melanoma multicellular spheroids initiated directly from surgical specimens of tumours in man
1987
Radiation response of human melanoma multicellular spheroids measured as single cell survival, growth delay, and spheroid cure: Comparisons with the parent tumor xenograft
1986
Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers.
2001
Metal Complexes as Photo- and Radiosensitizers
1999
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
2005 Standout
Hypoxia-inducible Factor-1 Mediates Transcriptional Activation of the Heme Oxygenase-1 Gene in Response to Hypoxia
1997 StandoutNobel
Cancer statistics in China, 2015
2016 Standout
Human papillomavirus infection and invasive cervical cancer in Paraguay
2000
Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women
2006
Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies
2007
HPV types and cofactors causing cervical cancer in Peru
2001
The role of microRNA genes in papillary thyroid carcinoma
2005 Standout
Prevalence of Human Papillomavirus DNA in Different Histological Subtypes of Cervical Adenocarcinoma
2000
Cell and Environment Interactions in Tumor Microregions: The Multicell Spheroid Model
1988 StandoutScience
Radiation response of multicellular spheroids initiated from five human melanoma xenograft lines. Relationship to the radioresponsivenessin vivo
1986
Human Papillomavirus and Cervical Cancer
2003 Standout
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
2009
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
The linear-quadratic formula and progress in fractionated radiotherapy
1989 Standout
Correlates of the spread of human papillomavirus infection.
2000
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries
2005
Native State Kinetic Stabilization as a Strategy To Ameliorate Protein Misfolding Diseases: A Focus on the Transthyretin Amyloidoses
2005
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
1997 Standout
Modifiable Risk Factors Associated with Clearance of Type-Specific Cervical Human Papillomavirus Infections in a Cohort of University Students
2005
Global cancer statistics, 2012
2015 Standout
Human papillomavirus infection among women in South and North Vietnam
2003
Increasing risk of uterine cervical cancer among young Japanese women: Comparison of incidence trends in Japan, South Korea and Japanese‐Americans between 1985 and 2012
2018
Attributable fractions: fundamental concepts and their visualization
2001
Works of Judith Deacon being referenced
The viral origin of cervical cancer in Rabat, Morocco
1998
Risk Factors for Cervical Cancer in Thailand: a Case-Control Study
1998
Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case–control study nested within the Manchester cohort
2000
Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort
2004
Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20–44 years: the UK National Case–Control Study of Cervical Cancer
2003
Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer
1999
Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk
1993
A toxicity and pharmacokinetic study in man of the hypoxic-cell radiosensitiser RSU-1069
1986
The radioresponsiveness of human tumours and the initial slope ofthe cell survival curve
1984
Causes of Cervical Cancer in the Philippines: a Case-Control Study
1998
The viral origin of cervical cancer in Rabat, Morocco
1998
The radiobiology of human neuroblastoma
1985